A sandwich-configuration electrochemiluminescence immunoassay based on Cu2O@OMC-Ru nanocrystals and OMC-MoS2 nanocomposites for determination of alpha-fetoprotein
A sandwich-format electrochemiluminescence (ECL) immunosensor has been developed for alpha-fetoprotein (AFP) detection based on the use of ordered mesoporous carbon-molybdenum disulfide (OMC-MoS 2 ) as a sensor platform and cuprous oxide @ ordered mesoporous carbon-Ru(bpy) 3 2+ (Cu 2 O@OMC-Ru) compo...
Gespeichert in:
Veröffentlicht in: | Mikrochimica acta (1966) 2021-06, Vol.188 (6), p.213-213, Article 213 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A sandwich-format electrochemiluminescence (ECL) immunosensor has been developed for alpha-fetoprotein (AFP) detection based on the use of ordered mesoporous carbon-molybdenum disulfide (OMC-MoS
2
) as a sensor platform and cuprous oxide @ ordered mesoporous carbon-Ru(bpy)
3
2+
(Cu
2
O@OMC-Ru) composites as signal tags. OMC alongside MoS
2
plays a synergistic role in improving the electrochemical performance of the electrode in the electron transfer process. The uniform cubic-shaped Cu
2
O@OMC-Ru nanocrystals display excellent luminous efficiency, with a signal amplification strategy of OMC-MoS
2
synergistic enhancement and Cu
2
O@OMC which is capable of immobilizing more Ru(bpy)
3
2+
serving as a tracing tag to label antibodies. A detectable ECL emission at a Cu
2
O@OMC-Ru nanocrystals modified electrode is initiated at an applied voltage of +1.15 V (scanning range: 0–1.2 V), in the presence of the tripropylamine (TPA) as coreactant. With the increase in AFP concentration, the loading of Cu
2
O@OMC-Ru at the electrode increases. Afterward, the ECL detection of AFP shows a wide linear range from 0.1 pg/mL to 10 ng/mL with a correlation coefficient of 0.9964 and a detection limit of 0.011 pg/mL (S/
N
= 3) under the optimal experimental conditions. The recoveries were in the range 91.2–97.1% with RSD varying from 4.8 to 8.5%. Overall, the novel immunosensor has been successfully applied to the analysis of human serum samples, indicating a great potential for application in clinical diagnostics.
Graphical abstract |
---|---|
ISSN: | 0026-3672 1436-5073 |
DOI: | 10.1007/s00604-021-04848-4 |